Techno Trends

TechnoTrends provide comprehensive coverage of the innovations and inventions in pharma products and pharma technologies across the world. The up-to-date listing of latest pharmaceutical product news and technology trends in the global pharma industry, keeps you abreast with all the latest pharmaceutical innovations happening world over.

Avidity Biosciences Discovers Novel Delpacibart Etedesiran (AOC 1001) for Myotonic Dystrophy Type 1

Avidity Biosciences has pioneered a groundbreaking treatment, del-desiran, for Myotonic Dystrophy Type 1. This investigational therapy targets the root cause...

Pfizer Launches First TIVDAK® to Treat Recurrent or Metastatic Cervical Cancer

Pfizer has introduced TIVDAK® to address the needs of patients battling recurrent or metastatic cervical cancer that has progressed despite prior chemotherapy. ...

The University of Texas MD Anderson Cancer Centre Develops Breakthrough PRAME-targeted TCR NK Cell Therapy

The University of Texas MD Anderson Cancer Centre has developed PRAME TCR/IL-15 NK, a revolutionary therapy using engineered T cell receptor natural killer cells to target relapsed/refractory myeloid malignancies....

ImmunityBio Discovered Novel Anktiva for Non-Muscle Invasive Bladder Cancer

ImmunityBio has developed a groundbreaking treatment for BCG-unresponsive non-muscle invasive bladder cancer with carcinoma in situ, called Anktiva. This innovative therapy combines Anktiva...

Kura Oncology Introduces Breakthrough Therapy for Ziftomenib in Mutant Acute Myeloid Leukaemia

Kura Oncology has introduced ziftomenib, a groundbreaking medication aimed at treating patients suffering from relapsed/refractory NPM1-mutant acute myeloid leukaemia...

Genentech Discovered First Alecensa® Treatment for Early-Stage Lung Cancer

Genentech has discovered the first-ever Alecensa® for adjuvant treatment after tumour removal in patients with anaplastic lymphoma kinase positive non-small cell lung cancer...

Johns Hopkins Medicine Developed Novel Treatment for Leukaemias and Lymphomas

Johns Hopkins Medicine has pioneered a groundbreaking treatment for T-cell leukaemias and lymphomas, addressing a critical challenge in targeting these cancers while preserving the immune system. ...

Dizal Discovered First-0f-its-kind Sunvozertinib Treatment

Dizal has discovered sunvozertinib as a groundbreaking first-line treatment for individuals with locally advanced or metastatic non-small cell lung cancer carrying epidermal growth factor receptor...

Denovo Biopharma Launches First-in-Class Liafensine for Treating Depression

Denovo Biopharma has introduced DB104, a pioneering treatment for treatment-resistant depression. Liafensine operates as a groundbreaking triple reuptake inhibitor, aiming at serotonin,...

Legend Biotech Launched First and Only CARVYKTI® BCMA-Targeted CAR-T Cell Therapy

Legend Biotech has introduced CARVYKTI®, the pioneering BCMA-Targeted CAR-T cell therapy aimed at treating individuals with relapsed or refractory multiple myeloma...